Second published study to demonstrate the potential therapeutic utility and mechanism of action of KETABET (patented combination of ketamine and betaine) in models of depression Repeated use of KETABET exhibits potential protective and reversing effects on ketamine-elicited psychotomimetic behaviors and cognitive impairments Supports clinical initiatives as a potential next generation ketamine…


Previous articlePsychedelic Drug Policy Reform in 2021
Next articlePT282 – Rabbi Zac Kamenetz & The Rev. Hunt Priest – Judaism, Christianity, and Embracing Psychedelics